| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 728809 | 85188 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFAMED 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFAMED 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85188/85188_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85188/85188_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 1 | 2020-11-09 | View Edit Delete | ||||||||||||
| 728808 | 85187 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFAMED 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFAMED 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85187/85187_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85187/85187_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 1 | 2020-11-09 | View Edit Delete | ||||||||||||
| 728807 | 85186 | DARUNAVIR TARBIS 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DARUNAVIR TARBIS 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 800 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85186/85186_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85186/85186_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 0 | 2021-01-27 | View Edit Delete | ||||||||||||
| 728806 | 85185 | DARUNAVIR TARBIS 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DARUNAVIR TARBIS 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 600 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85185/85185_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85185/85185_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 0 | 2021-01-27 | View Edit Delete | ||||||||||||
| 728805 | 85184 | DARUNAVIR TARBIS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DARUNAVIR TARBIS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85184/85184_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85184/85184_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 0 | 2021-01-27 | View Edit Delete | ||||||||||||
| 728804 | 85183 | ACICLOVIR BRILL PHARMA 30 MG/G POMADA OFTALMICA | ACICLOVIR BRILL PHARMA 30 MG/G POMADA OFTALMICA, 1 tubo de 4,5 g | 30 mg/g | 44 | 4,5 | 21 | 1 tubo de 4,5 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85183/85183_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85183/85183_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44573 | BRILL PHARMA S.L. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 0 | 2021-05-14 | View Edit Delete | ||||||||||||
| 728800 | 85182 | AMOXICILINA/ACIDO CLAVULANICO TARBIS FARMA 875 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMOXICILINA/ACIDO CLAVULANICO TARBIS FARMA 875 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 875 mg/125 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85182/85182_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85182/85182_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2020-06-19 | 1 | 1 | 1 | 2020-06-20 | 2020-06-19 | 1 | 2020-10-21 | View Edit Delete | ||||||||||||
| 728801 | 85182 | AMOXICILINA/ACIDO CLAVULANICO TARBIS FARMA 875 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMOXICILINA/ACIDO CLAVULANICO TARBIS FARMA 875 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 875 mg/125 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85182/85182_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85182/85182_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2020-06-19 | 1 | 1 | 1 | 2020-06-20 | 2020-06-19 | 1 | 2020-10-21 | View Edit Delete | ||||||||||||
| 738376 | 85180 | ABRILIA 20 MG COMPRIMIDOS EFG | ABRILIA 20 MG COMPRIMIDOS EFG, 7 comprimidos (Blister Al/Al/PA-PVC) | 20 mg | 5 | 7 | 10 | 7 comprimidos (Blister Al/Al/PA-PVC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85180/85180_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85180/85180_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2022-04-29 | 0 | 2022-08-16 | View Edit Delete | ||||||||||||
| 738377 | 85180 | ABRILIA 20 MG COMPRIMIDOS EFG | ABRILIA 20 MG COMPRIMIDOS EFG, 14 comprimidos (Blister Al/Al/PA-PVC) | 20 mg | 5 | 14 | 10 | 14 comprimidos (Blister Al/Al/PA-PVC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85180/85180_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85180/85180_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2022-04-29 | 0 | 2022-08-16 | View Edit Delete | ||||||||||||
| 738380 | 85180 | ABRILIA 20 MG COMPRIMIDOS EFG | ABRILIA 20 MG COMPRIMIDOS EFG, 20 comprimidos (Bluister Al/Al/PA-PVC) | 20 mg | 5 | 20 | 10 | 20 comprimidos (Bluister Al/Al/PA-PVC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85180/85180_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85180/85180_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2022-04-29 | 0 | 2022-08-16 | View Edit Delete | ||||||||||||
| 728796 | 85179 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5MG/160MG/25MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85179/85179_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85179/85179_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 0 | 2020-10-14 | View Edit Delete | ||||||||||||
| 728795 | 85178 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5 MG/160 MG/12.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85178/85178_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85178/85178_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 0 | 2021-07-02 | View Edit Delete | ||||||||||||
| 728794 | 85177 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 320 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85177/85177_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85177/85177_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 728793 | 85176 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85176/85176_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85176/85176_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 728792 | 85175 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85175/85175_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85175/85175_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 0 | 2020-10-14 | View Edit Delete | ||||||||||||
| 728789 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728790 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728791 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728783 | 85173 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KRKA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KRKA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85173/85173_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85173/85173_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2020-06-15 | 1 | 1 | 1 | 2020-06-16 | 2020-06-15 | 1 | 2020-11-12 | View Edit Delete |
Page 184 of 1036, showing 20 records out of 20709 total, starting on record 3661, ending on 3680